Wall Street Week Ahead: A lump of coal for "Fiscal Cliff-mas"

NEW YORK (Reuters) - Wall Street traders are going to have to pack their tablets and work computers in their holiday luggage after all.


A traditionally quiet week could become hellish for traders as politicians in Washington are likely to fall short of an agreement to deal with $600 billion in tax hikes and spending cuts due to kick in early next year. Many economists forecast that this "fiscal cliff" will push the economy into recession.


Thursday's debacle in the U.S. House of Representatives, where Speaker John Boehner failed to secure passage of his own bill that was meant to pressure President Obama and Senate Democrats, only added to worry that the protracted budget talks will stretch into 2013.


Still, the market remains resilient. Friday's decline on Wall Street, triggered by Boehner's fiasco, was not enough to prevent the S&P 500 from posting its best week in four.


"The markets have been sort of taking this in stride," said Sandy Lincoln, chief market strategist at BMO Asset Management U.S. in Chicago, which has about $38 billion in assets under management.


"The markets still basically believe that something will be done," he said.


If something happens next week, it will come in a short time frame. Markets will be open for a half-day on Christmas Eve, when Congress will not be in session, and will close on Tuesday for Christmas. Wall Street will resume regular stock trading on Wednesday, but volume is expected to be light throughout the rest of the week with scores of market participants away on a holiday break.


For the week, the three major U.S. stock indexes posted gains, with the Dow Jones industrial average <.dji> up 0.4 percent, the S&P 500 <.spx> up 1.2 percent and the Nasdaq Composite Index <.ixic> up 1.7 percent.


Stocks also have booked solid gains for the year so far, with just five trading sessions left in 2012: The Dow has advanced 8 percent, while the S&P 500 has climbed 13.7 percent and the Nasdaq has jumped 16 percent.


IT COULD GET A LITTLE CRAZY


Equity volumes are expected to fall sharply next week. Last year, daily volume on each of the last five trading days dropped on average by about 49 percent, compared with the rest of 2011 - to just over 4 billion shares a day exchanging hands on the New York Stock Exchange, the Nasdaq and NYSE MKT in the final five sessions of the year from a 2011 daily average of 7.9 billion.


If the trend repeats, low volumes could generate a spike in volatility as traders keep track of any advance in the cliff talks in Washington.


"I'm guessing it's going to be a low volume week. There's not a whole lot other than the fiscal cliff that is going to continue to take the headlines," said Joe Bell, senior equity analyst at Schaeffer's Investment Research, in Cincinnati.


"A lot of people already have a foot out the door, and with the possibility of some market-moving news, you get the possibility of increased volatility."


Economic data would have to be way off the mark to move markets next week. But if the recent trend of better-than-expected economic data holds, stocks will have strong fundamental support that could prevent selling from getting overextended even as the fiscal cliff negotiations grind along.


Small and mid-cap stocks have outperformed their larger peers in the last couple of months, indicating a shift in investor sentiment toward the U.S. economy. The S&P MidCap 400 Index <.mid> overcame a technical level by confirming its close above 1,000 for a second week.


"We view the outperformance of the mid-caps and the break of that level as a strong sign for the overall market," Schaeffer's Bell said.


"Whenever you have flight to risk, it shows investors are beginning to have more of a risk appetite."


Evidence of that shift could be a spike in shares in the defense sector, expected to take a hit as defense spending is a key component of the budget talks.


The PHLX defense sector index <.dfx> hit a historic high on Thursday, and far outperformed the market on Friday with a dip of just 0.26 percent, while the three major U.S. stock indexes finished the day down about 1 percent.


Following a half-day on Wall Street on Monday ahead of the Christmas holiday, Wednesday will bring the S&P/Case-Shiller Home Price Index. It is expected to show a ninth-straight month of gains.


U.S. jobless claims on Thursday are seen roughly in line with the previous week's level, with the forecast at 360,000 new filings for unemployment insurance, compared with the previous week's 361,000.


(Wall St Week Ahead runs every Friday. Questions or comments on this column can be emailed to: rodrigo.campos(at)thomsonreuters.com)


(Reporting by Rodrigo Campos; Additional reporting by Chuck Mikolajczak; Editing by Jan Paschal)



Read More..

Syrian Resort Town Is Stronghold for Alawites





TARTUS, Syria — Loyalists who support the government of President Bashar al-Assad are flocking to the Mediterranean port of Tartus, creating an overflowing boomtown far removed from the tangled, scorched rubble that now mars most Syrian cities.







The New York Times

The port city of Tartus is sheltered by a mountain range.






There are no shellings or air raids to interrupt the daily calm. Families pack the cafes lining the town’s seaside corniche, usually abandoned in December to the salty winter winds. The real estate market is brisk. A small Russian naval base provides at least the impression that salvation, if needed, is near.


Many of the new residents are members of the Alawite minority, the same Shiite Muslim sect to which Mr. Assad belongs. The latest influx is fleeing from Damascus, people who have decided that summer villas, however chilly, are preferable to the looming battle for the capital.


“Going to Tartus is like going to a different country,” said a Syrian journalist who recently met residents here. “It feels totally unaffected and safe. The attitude is, ‘We are enjoying our lives while our army is fighting overseas.’ ”


Should Damascus fall to the opposition, Tartus could become the heart of an attempt to create a different country. Some expect Mr. Assad and the security elite will try to survive the collapse by establishing a rump Alawite state along the coast, with Tartus as their new capital.


There have been various signs of preparations.


This month, the governor of Tartus Province announced that experts were studying how to develop a tiny local airfield, now used mostly by crop-dusters, into a full-fledged civilian airport “to boost transportation, business, travel and tourism,” as the official Syrian news agency, SANA, reported. The announcement coincided with the first attacks on the airport in Damascus, forcing it to close temporarily to international traffic.


More important, security forces are continuously tightening an extensive ring of checkpoints around the potential borders of an Alawite canton. The mountain heartland of the Alawites rises steeply to the east of Tartus, separating it from much of Syria. Across the mountains, the Orontes River creates a rough line separating Alawite territory from central Syria. Rebel military commanders from adjoining Hama Province said government soldiers vigorously maintain checkpoints on routes leading up into the mountains.


“If we bomb a checkpoint, it is back in place sometimes within hours,” said Basil al-Hamwi, a rebel fighter, speaking on the sidelines of a meeting of opposition military commanders in Turkey. “Once, in Hama Province, we destroyed five in one day and they were all back the next day. This area is even more important for them than Damascus.”


Mr. Hamwi and other commanders said there were about 40 government checkpoints along more than 60 miles in Homs and Hama Provinces alone. Many Alawite commanders of Mr. Assad’s army have sent their families to their home villages, so they are particularly aggressive in protecting the area, said Hassan M. al-Saloom, a rebel battalion commander. They have formed committees to guard the outskirts of their villages, he said, and often negotiate local truces.


“Nobody goes inside, and they don’t come out,” he said.


There are widespread suspicions within the opposition that the military is shipping weapons into the Alawite hinterland, or has already positioned them. “The mountains and the coast make it hard to raid,” Mr. Saloom said.


Castles left by the Crusaders dot the coastal range, a testament to its strategic value.


If Mr. Assad fled to Tartus, he could seek protection from the Russian naval base here, or flee aboard a Russian vessel. Russia announced Tuesday that it was sending a small flotilla toward Tartus, possibly to evacuate its citizens who live in Syria. But Tartus residents said that the Russian families from the naval base had already left, while the officers do not leave the base, which is little more than an enclosure near the civilian port.


An employee of The New York Times reported from Tartus, and Neil MacFarquhar from Antakya, Turkey. Hania Mourtada contributed reporting from Beirut, Lebanon, and Hala Droubi from Dubai, United Arab Emirates.



Read More..

Massive PC, Console Game Discounts Ring in Holiday Season






Black Friday, the day right after Thanksgiving, is normally the day associated with electronics sales. And while the proponents of “Cyber Monday” and “Small Business Saturday” have tried to get in on the action, it’s still common knowledge that Thanksgiving weekend is the best time to upgrade your PC or console game arsenal. Right?


Not according to online game retailers. Discounts of up to 80 percent off a game’s retail price are taking place across the web, especially in online stores which offer games in the form of digital downloads (which cost nothing to make extra copies of). Here’s a look at just a few of the sales going on right now, for Windows and Linux PCs, Macs, game consoles, and mobile devices.






Steam (Windows, Linux, Mac)


The annual Steam Holiday Sale is under way, and it’s not just blowing hot air. Complete collections of every Steam game from publishers including Valve are on sale for around the price of one retail title, and individual games can be bought from each bundle for only a few dollars. Each day new sales are available, and most of them are massive, percentage-wise. They’re tied to a personal Steam account (which will always be linked to the original name they were created with), but can be bought as gifts for others.


Also check out: Amazon.com’s PC download sales, many of which are fulfilled through Steam and are discounted about as much. Amazon’s lineup also includes many casual games, of the “$ 10 store discount rack” variety.


Humble Indie Bundle 7 (Windows, Linux, Mac)


The Humble Bundle crew has been offering cross-platform, name-your-own-price bundles of indie games for several years now, and their seventh numbered offering is timed right for the holiday season. Bundles are giftable, the games can be played on Steam, and you can choose how much of your purchase price goes to game developers and how much goes to select charities.


PlayStation Network (PS3, PSP, Vita)


Console gamers aren’t being left out. The PSN Holiday Essentials sale is putting “more than 40 titles” on sale over the next three weeks, with a new selection available every week and even lower prices available to PlayStation Plus members.


Also check out: The Xbox Live Countdown to 2013 sale, with a “Daily Deal” every day until the end of the year.


Other sales


Game publishers SEGA and Square-Enix are discounting many of their most popular titles. SEGA’s holiday sale includes PSN, Xbox Live, Android and iOS titles, with most of its mobile games selling for $ 0.99. Meanwhile, the Square-Enix Winter of Mobile sale page lists huge discounts on iPhone and iPad games, while Android Police blogger Jeremiah Rice has put together a list of which Square-Enix Android games are on sale.


Jared Spurbeck is an open-source software enthusiast, who uses an Android phone and an Ubuntu laptop PC. He has been writing about technology and electronics since 2008.
Linux/Open Source News Headlines – Yahoo! News





Title Post: Massive PC, Console Game Discounts Ring in Holiday Season
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

PEOPLE Remembers the American Soldiers Killed in Afghanistan

With the exit from Iraq and the draw-down of troops in Afghanistan, the numbers of Americans killed continues to drop.

Still, loved ones are mourning 311 lost, and as of Dec. 17, the wars' toll since 2001 now stands at 6,656.

Edward Joseph Acosta, 21
Trevor Brandon Adkins, 21
Ahmed Kousay al-Taie, 46 Erica Paige Alecksen, 21
Tobias Christoph Alexander, 30
Joseph James Altmann, 27
Mabry James Anders, 21
Joshua Ryan Ashley, 23
Bradley Wayne Atwell, 27

Daniel Benjamin Bartle, 27
Jon-Luke Bateman, 22
Jonathan Batista, 22
Rayvon Battle Jr., 25
Taylor John Baune, 21
Jordan Logan Bear, 25
Clayton Ross Beauchamp, 21
Genaro Bedoy, 20
Bryan Richard Bell, 23
Russell Ryan Bell, 37
Jose Oscar Belmontes, 28
Kenneth Wade Bennett, 26
Keith David Benson, 27
Richard Liam Berry, 27
Robert John Billings, 30
Christopher James Birdwell, 25
Jeremie Shane Border, 28
Christopher David Bordoni, 21
Joshua Alan Born, 25
Michael Cean Braden, 31
Mikayla Anne Bragg, 21
John R. Brainard III, 26
Sean Edward Brazas, 26
Andrew Trevor Britton-Mihalo, 25
Michael John Brodsky, 33
Christopher L. Brown, 26
Daniel Joseph Brown, 27
Milton W. Brown, 28
Gregory Thomas Buckley, 21
Antonio Carlos Burnside, 31
Thomas Jefferson Butler IV, 25
Brandon Lucas Buttry, 19

Gerardo Campos, 23
Shane William Cantu, 20
Daniel Lewis Carlson, 21
Sean Patrick Carson, 32
Roberto Cazarez, 24
Julian Clement Chase, 22
Nicolas D. Checque, 28
Gregory Lamont Childs, 38
Bruce Kevin Clark, 43
Junot M. L. Cochilus, 34
Kenneth Eldren Cochran, 20
Keaton Grant Coffey, 22
Julian Lee Colvin, 21
Timothy John Conrad Jr., 22
Gregory Todd Copes, 36
Cesar Cortez, 24
Niall William Cotisears, 23

Joseph D’Augustine, 29
Johnathon Frank Davis, 20
Nathan Tyler Davis, 20
Coater Bernard Debose, 55
Michael Robert Demarsico II, 20
Anthony Joseph Denier, 26
Leroy Deronde III, 22
Nicholas Michael Dickhut, 23
Scott Edward Dickinson, 29
Alex Frank Domion, 21
Curtis Joseph Duarte, 22
Michael Stephen Duskin, 42
James Evan Dutton, 25
Edward Joe Dycus, 22

Kevin Richard Ebbert, 32
Jason Kyle Edens, 22
Brandon Forrest Eggleston, 29
Vincent James Ellis, 22
Darrel Lynn Enos, 36
Richard Allen Essex, 23
Bobby Lee Estle, 38
Kyler Lavon Estrada, 21

Joseph Henry Fankhauser, 30
Aaron Matthew Faust, 22
Mathew Gregory Fazzari, 25
Patrick Delaney Feeks, 28
Arronn David Fields, 27
Krystal Marie Fitts, 26
Joseph Fitzmorris, 31
Thomas Kent Fogarty, 30
Nicholas Charles Fredsti, 30

Vilmar Galarza Hernandez, 21
Luis Antonio Oliver Galbreath, 41
Jonathan William Gifford, 34
Theodore Matthew Glende, 23
Jonathan Alan Gollnitz, 28
Moises Jesus Gonzalez, 29
Brandon Dwayne Goodine, 20
Brittany Bria Gordon, 24
Brett Edward Gornewicz, 27
Walter David Gray, 38
Kevin James Griffin, 45
Samuel Mark Griffith, 36
Jesse James Grindey, 30
Dustin Dean Gross, 19
Raul Madrigal Guerra, 37
Michael J. Guillory, 28

Ryan Preston Hall, 30
Carl Erik Hammar, 24
Shawn Thomas Hannon, 44
John Eric Hansen, 41
Justin Michael Hansen, 26
Jeremy Franklin Hardison, 23
Zachary Hayden Hargrove, 32
Aaron Arthur Henderson, 33
Alex Hernandez III, 21
Pernell Johnnie Herrera, 33
Channing Bo Hicks, 24
Darrion Terrell Hicks, 21
Tanner Stone Higgins, 23
Terence John Hildner, 49
Hunter Dalton Hogan, 21
Eric Scott Holman, 39
Patricia Lee Horne, 20
Brian Daniel Hornsby, 37
Justin Louis Horsley, 21
John Patrick Huling, 25

Francis Dee Imlay Jr., 31
Aaron Dale Istre, 37

Kedith Lamont Jacobs Jr., 21
Sean Robert Jacobs, 23
Jamie Darrell Jarboe, 27
Ryan Paul Jayne, 22
Ryan Jeschke, 31
David Andrew Johnson, 24
Donna Rae Johnson, 29
Nicholas Scott Johnson, 27
Payton Alexander Jones, 19
James Austin Justice, 21

Ramon Taisakan Kaipat, 22
Matthew Geoffrey Kantor, 22
Andrew James Keller, 22
Thomas Elliott Kennedy, 35
Kurt William Kern, 24
Richard James Kessler Jr., 47
Michael Joseph Knapp, 28
Jabraun Steven Knox, 23
Noah Mark Korte, 29
Suresh Niranjan Aba Krause, 29

Jarrod Allen Lallier, 20
Todd William Lambka, 25
Matthew John Leach, 29
Dick Alson Lee Jr., 31
Brian Jeffery Leonhardt, 21
Joseph Michael Lilly, 25
Darren M. Linde, 41
Daniel Lee Linnabary II, 23
Kevin E. Lipari, 39
Roberto Loeza Jr., 28
John Darin Loftis, 44
Joseph Daniel Logan, 22
Jesus Jonathan Lopez, 22
Conner Thomas Lowry, 24
Bryant Jordan Luxmore, 25

Bruce Andrew MacFarlane, 46
Thomas Raymond MacPherson, 26
Matthew Patrick Manoukian, 29
Robert Joseph Marchanti II, 48
Justin Cameron Marquez, 25
Chase Stone Marta, 24
Ethan Jacob Martin, 22
Alex Martinez, 21
Robert Anthony Massarelli, 32
Erik Nathaniel May, 26
Kyle Brenton McClain, 25
Philip Daine McGeath, 25
Nathan Ronald McHone, 29
Allen Robert McKenna Jr., 28
Barett Wambli McNabb, 33
Richard Lewis McNulty III, 22
John David Meador II, 36
Dale Wayne Means, 23
Kashif Mohammed Memon, 31
Michael Joseph Metcalf, 22
Daniel Thomas Metcalfe, 29
Jonathan Matthew Metzger, 32
Cale Clyde Miller, 23
Eugene Clifton Mills III, 21
Christopher Michael Monahan Jr., 25
Jose Luis Montenegro Jr., 31
Osbrany Montes De Oca, 20
Cody Otho Moosman, 24
Travis Alan Morgado, 25
Christopher E. Mosko, 28
Sky Russell Mote, 27
Christopher Lee Muniz, 24

Dustin Paul Napier, 20
Juan Pantoja Navarro, 23
Benjamin Harold Neal, 21
James Dominic Nehl, 37
Joshua Nathaniel Nelson, 22
Sapuro Brightley Nena, 25
David Paul Nowaczyk, 32
Israel Paul Nuanes, 38

Nicholas Henry Olivas, 20
Tyler J. Orgaard, 20
Kyle Bruce Osborn, 26
Jesse Aaron Ozbat, 28

Scott Patrick Pace, 39
Joshua Cole Pairsh, 29
Michael Jeremy Palacio, 23
Alejandro Jose Pardo, 21
Christopher Alexander Patterson, 20
Brandon Robert Pepper, 31
Sergio Eduardo Perez, 21
Trevor Adam Pinnick, 20
Benjamin Carlos Pleitez, 25
William Compton Poling Jr., 42
Paris Shawn Pough, 40
Alexander George Povilaitis Jr., 47
Stephen Chase Prasnicki, 24
John Castle Pratt, 51
Daniel Joseph Price, 27
Scott Eugene Pruitt, 38
Michael Wayne Pyron, 30

Christopher Keith Raible, 40
Thalia Suzanne Ramirez, 28
Ryan Davis Rawl, 30
Clovis Tim Ray, 34
Jerry Don Reed II, 30
Chad Robert Regelin, 24
Nicholas J. Reid, 26
Kevin James Reinhard, 25
Jose Joel Reyes, 24
Jeffrey Leon Rice, 24
Joseph Alvin Richardson, 23
Travis William Riddick, 40
Jeffrey James Rieck, 46
Michael Eugene Ristau, 25
Richard Anthony Rivera Jr., 20
Daquane Demetris Rivers, 21
Dion Rashun Roberts, 25
Leonard Robinson, 29
Daniel Anthony Rodriguez, 28
Jose Rodriguez, 22
Kyle Robert Rookey, 23
Adam Corey Ross, 19
Nicholas Jan Rozanski, 36
Clinton Keith Ruiz, 22
David E. Rylander, 23

Brenden Neal Salazar, 20
Christian Riley Sannicolas, 20
Ryan James Savard, 29
Philip Channing Sipe Schiller, 21
Joseph Lee Schiro, 27
Jonathan Philip Schmidt, 28
Julian Seiji Scholten, 26
Jacob Michael Schwallie, 22
Matthew Scott Schwartz, 34
Matthew Ryan Seidler, 24
Ricardo Seija, 31
Anthony Ramon Servin, 22
Dean Russell Shaffer, 23
Christopher Greg Singer, 23
Matthew Steven Sitton, 26
James Lyn Skalberg Jr., 25
Tyler James Smith, 24
Orion Nelson Sparks, 29
William Chapman Stacey, 23
Cameron James Stambaugh, 20
Trevor Jovanne Stanley, 22
Camella Marchett Steedley, 31
Riley Gene Stephens, 39
Steven Prince Stevens II, 23
Matthew Henrick Stiltz, 26
Jesse Wade Stites, 23
Michael Joseph Strachota, 28
Sean Patrick Sullivan, 40
Billy Albert Sutton, 42
Steven Gene Sutton, 24
Jason Michael Swindle, 24

Abraham Tarwoe, 25
Robert Joseph Tauteris Jr., 44
Tofiga Joshua Tautolo, 23
David Wayne Taylor, 20
Nicholas Andrew Taylor, 20
Alec Robert Terwiske, 21
Matthew Bradford Thomas, 30
Alejo Rene Thompson, 30
Joel Del Mundo Tiu, 48
Louis Ramon Torres, 23
Jon Ross Townsend, 19
Gregory Ray Trent, 38
Nelson D. Trent, 37
Neil Isaac Turner, 21

Jalfred David Vaquerano, 20
Manuel Joseph Vasquez, 22
Jorge Luis Velasquez, 35
Dain Taylor Venne, 29
Don Cayetano Viray, 25
Paul Clarke Voelke, 36

Brian Lloyd Walker, 25
Jonathan Patrick Walsh, 28
Eric Dean Warren, 23
David John Warsen, 27
Samuel Thomas Watts, 20
Dennis Paul Weichel Jr., 29
Jeffrey Lee White Jr., 21
Nicholas Schade Whitlock, 29
Justin Michael Whitmire, 20
Ronald Herbert Wildrick Jr., 30
Justin James Wilkens, 26
Clarence Williams III, 23
David Vincent Williams, 24
Eric Edward Williams, 27
Wesley R. Williams, 25
Ryan James Wilson, 26
Shane Gregory Wilson, 20
Wade Daniel Wilson, 22
William Robert Wilson III, 27
Jessica Marie Wing, 42
Benjamin Brian Wise, 34
Joshua Eli Witsman, 23
Chris John Workman, 33
Sterling William Wyatt, 21

Read More..

Predicting who's at risk for violence isn't easy


CHICAGO (AP) — It happened after Columbine, Virginia Tech, Aurora, Colo., and now Sandy Hook: People figure there surely were signs of impending violence. But experts say predicting who will be the next mass shooter is virtually impossible — partly because as commonplace as these calamities seem, they are relatively rare crimes.


Still, a combination of risk factors in troubled kids or adults including drug use and easy access to guns can increase the likelihood of violence, experts say.


But warning signs "only become crystal clear in the aftermath, said James Alan Fox, a Northeastern University criminology professor who has studied and written about mass killings.


"They're yellow flags. They only become red flags once the blood is spilled," he said.


Whether 20-year-old Adam Lanza, who used his mother's guns to kill her and then 20 children and six adults at their Connecticut school, made any hints about his plans isn't publicly known.


Fox said that sometimes, in the days, weeks or months preceding their crimes, mass murderers voice threats, or hints, either verbally or in writing, things like "'don't come to school tomorrow,'" or "'they're going to be sorry for mistreating me.'" Some prepare by target practicing, and plan their clothing "as well as their arsenal." (Police said Lanza went to shooting ranges with his mother in the past but not in the last six months.)


Although words might indicate a grudge, they don't necessarily mean violence will follow. And, of course, most who threaten never act, Fox said.


Even so, experts say threats of violence from troubled teens and young adults should be taken seriously and parents should attempt to get them a mental health evaluation and treatment if needed.


"In general, the police are unlikely to be able to do anything unless and until a crime has been committed," said Dr. Paul Appelbaum, a Columbia University professor of psychiatry, medicine and law. "Calling the police to confront a troubled teen has often led to tragedy."


The American Academy of Child & Adolescent Psychiatry says violent behavior should not be dismissed as "just a phase they're going through."


In a guidelines for families, the academy lists several risk factors for violence, including:


—Previous violent or aggressive behavior


—Being a victim of physical or sexual abuse


—Guns in the home


—Use of drugs or alcohol


—Brain damage from a head injury


Those with several of these risk factors should be evaluated by a mental health expert if they also show certain behaviors, including intense anger, frequent temper outbursts, extreme irritability or impulsiveness, the academy says. They may be more likely than others to become violent, although that doesn't mean they're at risk for the kind of violence that happened in Newtown, Conn.


Lanza, the Connecticut shooter, was socially withdrawn and awkward, and has been said to have had Asperger's disorder, a mild form of autism that has no clear connection with violence.


Autism experts and advocacy groups have complained that Asperger's is being unfairly blamed for the shootings, and say people with the disorder are much more likely to be victims of bullying and violence by others.


According to a research review published this year in Annals of General Psychiatry, most people with Asperger's who commit violent crimes have serious, often undiagnosed mental problems. That includes bipolar disorder, depression and personality disorders. It's not publicly known if Lanza had any of these, which in severe cases can include delusions and other psychotic symptoms.


Young adulthood is when psychotic illnesses typically emerge, and Appelbaum said there are several signs that a troubled teen or young adult might be heading in that direction: isolating themselves from friends and peers, spending long periods alone in their rooms, plummeting grades if they're still in school and expressing disturbing thoughts or fears that others are trying to hurt them.


Appelbaum said the most agonizing calls he gets are from parents whose children are descending into severe mental illness but who deny they are sick and refuse to go for treatment.


And in the case of adults, forcing them into treatment is difficult and dependent on laws that vary by state.


All states have laws that allow some form of court-ordered treatment, typically in a hospital for people considered a danger to themselves or others. Connecticut is among a handful with no option for court-ordered treatment in a less restrictive community setting, said Kristina Ragosta, an attorney with the Treatment Advocacy Center, a national group that advocates better access to mental health treatment.


Lanza's medical records haven't been publicly disclosed and authorities haven't said if it is known what type of treatment his family may have sought for him. Lanza killed himself at the school.


Jennifer Hoff of Mission Viejo, Calif. has a 19-year-old bipolar son who has had hallucinations, delusions and violent behavior for years. When he was younger and threatened to harm himself, she'd call 911 and leave the door unlocked for paramedics, who'd take him to a hospital for inpatient mental care.


Now that he's an adult, she said he has refused medication, left home, and authorities have indicated he can't be forced into treatment unless he harms himself — or commits a violent crime and is imprisoned. Hoff thinks prison is where he's headed — he's in jail, charged in an unarmed bank robbery.


___


Online:


American Academy of Child & Adolescent Psychiatry: http://www.aacap.org


___


AP Medical Writer Lindsey Tanner can be reached at http://www.twitter.com/LindseyTanner


Read More..

Wall Street Week Ahead: A lump of coal for "Fiscal Cliff-mas"

NEW YORK (Reuters) - Wall Street traders are going to have to pack their tablets and work computers in their holiday luggage after all.


A traditionally quiet week could become hellish for traders as politicians in Washington are likely to fall short of an agreement to deal with $600 billion in tax hikes and spending cuts due to kick in early next year. Many economists forecast that this "fiscal cliff" will push the economy into recession.


Thursday's debacle in the U.S. House of Representatives, where Speaker John Boehner failed to secure passage of his own bill that was meant to pressure President Obama and Senate Democrats, only added to worry that the protracted budget talks will stretch into 2013.


Still, the market remains resilient. Friday's decline on Wall Street, triggered by Boehner's fiasco, was not enough to prevent the S&P 500 from posting its best week in four.


"The markets have been sort of taking this in stride," said Sandy Lincoln, chief market strategist at BMO Asset Management U.S. in Chicago, which has about $38 billion in assets under management.


"The markets still basically believe that something will be done," he said.


If something happens next week, it will come in a short time frame. Markets will be open for a half-day on Christmas Eve, when Congress will not be in session, and will close on Tuesday for Christmas. Wall Street will resume regular stock trading on Wednesday, but volume is expected to be light throughout the rest of the week with scores of market participants away on a holiday break.


For the week, the three major U.S. stock indexes posted gains, with the Dow Jones industrial average <.dji> up 0.4 percent, the S&P 500 <.spx> up 1.2 percent and the Nasdaq Composite Index <.ixic> up 1.7 percent.


Stocks also have booked solid gains for the year so far, with just five trading sessions left in 2012: The Dow has advanced 8 percent, while the S&P 500 has climbed 13.7 percent and the Nasdaq has jumped 16 percent.


IT COULD GET A LITTLE CRAZY


Equity volumes are expected to fall sharply next week. Last year, daily volume on each of the last five trading days dropped on average by about 49 percent, compared with the rest of 2011 - to just over 4 billion shares a day exchanging hands on the New York Stock Exchange, the Nasdaq and NYSE MKT in the final five sessions of the year from a 2011 daily average of 7.9 billion.


If the trend repeats, low volumes could generate a spike in volatility as traders keep track of any advance in the cliff talks in Washington.


"I'm guessing it's going to be a low volume week. There's not a whole lot other than the fiscal cliff that is going to continue to take the headlines," said Joe Bell, senior equity analyst at Schaeffer's Investment Research, in Cincinnati.


"A lot of people already have a foot out the door, and with the possibility of some market-moving news, you get the possibility of increased volatility."


Economic data would have to be way off the mark to move markets next week. But if the recent trend of better-than-expected economic data holds, stocks will have strong fundamental support that could prevent selling from getting overextended even as the fiscal cliff negotiations grind along.


Small and mid-cap stocks have outperformed their larger peers in the last couple of months, indicating a shift in investor sentiment toward the U.S. economy. The S&P MidCap 400 Index <.mid> overcame a technical level by confirming its close above 1,000 for a second week.


"We view the outperformance of the mid-caps and the break of that level as a strong sign for the overall market," Schaeffer's Bell said.


"Whenever you have flight to risk, it shows investors are beginning to have more of a risk appetite."


Evidence of that shift could be a spike in shares in the defense sector, expected to take a hit as defense spending is a key component of the budget talks.


The PHLX defense sector index <.dfx> hit a historic high on Thursday, and far outperformed the market on Friday with a dip of just 0.26 percent, while the three major U.S. stock indexes finished the day down about 1 percent.


Following a half-day on Wall Street on Monday ahead of the Christmas holiday, Wednesday will bring the S&P/Case-Shiller Home Price Index. It is expected to show a ninth-straight month of gains.


U.S. jobless claims on Thursday are seen roughly in line with the previous week's level, with the forecast at 360,000 new filings for unemployment insurance, compared with the previous week's 361,000.


(Wall St Week Ahead runs every Friday. Questions or comments on this column can be emailed to: rodrigo.campos(at)thomsonreuters.com)


(Reporting by Rodrigo Campos; Additional reporting by Chuck Mikolajczak; Editing by Jan Paschal)



Read More..

U.N. Panel Votes to Help Mali’s Army Oust Extremists





The United Nations Security Council unanimously approved a resolution on Thursday that will send thousands of African troops into the desert nation of Mali to help oust Islamist extremists who have turned its northern half into a vast Qaeda enclave and training ground, menacing the stability of neighboring states and posing a potent new international terrorism threat.




But the resolution also makes it clear that such a military intervention will not happen until Mali’s own dysfunctional army is adequately trained and a framework for political stability and elections is restored in the country, which has been in turmoil since a military coup in March.


The resolution, which was sponsored by France, the former colonial power in Mali, does not specify a time frame for the first deployment of foreign troops, to be supplied by a group of West African nations that are eager to see calm restored in Mali. United Nations officials and diplomats who worked on the resolution said that a 3,300-soldier force would be sent, and that any attempt to drive the Islamists from northern Mali would not happen before September or October at the earliest.


The resolution does not explain precisely how the military expedition, which is to last for an initial period of one year, will be financed, although diplomats said they expected the cost to exceed $200 million. The resolution calls for voluntary contributions from member states into a trust fund to be created by Secretary General Ban Ki-moon.


Despite the caveats, the Security Council’s vote authorizing military force, which it is empowered to do by the United Nations Charter, represented a rare moment of decisive unanimity among its 15 member states and in particular its 5 permanent members — Britain, China, France, Russia and the United States — in a year punctuated by bitter disagreements, mostly over the Syrian conflict.


“Everyone knows the complexity of the task facing the international community to restore the territorial integrity of Mali and to put an end to terrorist activities in the north of the country,” GĂ©rard Araud, France’s ambassador, told reporters after the vote. The resolution, he said, “provides a reasonable answer.”


Ideally, Mr. Araud said, the mere threat of military intervention would persuade Islamist militia leaders to negotiate a peaceful restoration of control by Mali’s central government. “It is premature to indicate when the military operation will take place,” he said. “In fact, the question is even whether the military operation will take place. Our goal would be to have a real political process which will allow the Malian Army to go back to its barracks in the northern part of the country without fighting.”


The final version of the resolution reflected what diplomats called some compromises between France and the United States, which had been skeptical that the Malian Army could be made capable of participating in a potentially long and violent struggle to retake the country’s northern area, roughly twice the size of Germany.


The resolution specifies that the European Union will be responsible for training the Malian forces, described as “vital to ensure Mali’s long-term security and stability.” It also specifies that the secretary general must regularly inform the Council on political and military-training progress, and “confirm in advance the Council’s satisfaction with the planned military offensive operation.”


Language was also included specifically intended to guard against human rights abuses by the Malian military in any operation in the north, where ethnic tensions linked to the occupation by Islamist militants are known to be on the rise. A report released Thursday by Human Rights Watch enumerated instances of abuses in Mali committed by security forces and others since the military coup.


Tens of thousands of Malians have fled the north since Islamist militias seized control there after the coup, which left a power vacuum that has yet to be resolved. Just last week, military generals forced the resignation of Prime Minister Cheick Modibo Diarra, in office since April.


The principal Islamist militia, known as Ansar Dine, or Defenders of the Faith, has imposed harsh Shariah law based on strict Islamic tenets and enforced it with public killings, stonings and amputations. The group has also welcomed Al Qaeda in the Islamic Maghreb, the affiliate of Al Qaeda in northern Africa, which has recruited child soldiers, established training camps and reached out to other militant Islamist organizations, including Boko Haram, a particularly violent group in northern Nigeria.


Rights activists monitoring the Mali crisis had a mixed reaction to the Security Council resolution. While they welcomed action against abuses by the Islamists, some expressed concern that the Malian Army, humiliated by the loss of half the country, would be bent on revenge.


Michael Quinn, country director of the aid group Oxfam in Mali, said the Security Council “must make sure that any military planning includes humanitarian consideration to minimize harm to civilians at all stages.”


Read More..

Ashton Kutcher Files for Divorce from Demi Moore






People Exclusive








12/21/2012 at 03:55 PM EST







Ashton Kutcher and Demi Moore


Amanda Edwards/WireImage


After more than a year with their marriage in legal limbo, Ashton Kutcher has filed for divorce from Demi Moore.

The papers were filed Friday Los Angeles Superior Court. Kutcher, 34, citing irreconcilable differences, isn't seeking any spousal support nor is he asking the court to deny Moore any. The documents also show that because the couple had no children together, child support and visitation are not an issue.

Back in Nov. 2011, the couple announced they were ending their 6-year marriage.

"As a woman, a mother and a wife there are certain values and vows that I hold sacred, and it is in this spirit that I have chosen to move forward with my life," Moore, 50, said at the time, following reports of Kutcher's infidelity.

Added Kutcher: "I will forever cherish the time I spent with Demi. Marriage is one of the most difficult things in the world and unfortunately sometimes they fail."

The actor has been dating That '70s Show costar Mila Kunis.

The documents reveal that Kutcher has hired A-list divorce attorney Laura Wasser to represent him, whose past or current clients include Britney Spears, Kim Kardashian, Heidi Klum and Angelina Jolie, among others.

Read More..

AP IMPACT: Big Pharma cashes in on HGH abuse


A federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's biggest pharmaceutical companies, an Associated Press investigation shows.


The crackdown, which began in 2006, reduced the illegal flow of unregulated supplies from China, India and Mexico.


But since then, Big Pharma has been satisfying the steady desires of U.S. users and abusers, including many who take the drug in the false hope of delaying the effects of aging.


From 2005 to 2011, inflation-adjusted sales of HGH were up 69 percent, according to an AP analysis of pharmaceutical company data collected by the research firm IMS Health. Sales of the average prescription drug rose just 12 percent in that same period.


___


EDITOR'S NOTE — Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


___


Unlike other prescription drugs, HGH may be prescribed only for specific uses. U.S. sales are limited by law to treat a rare growth defect in children and a handful of uncommon conditions like short bowel syndrome or Prader-Willi syndrome, a congenital disease that causes reduced muscle tone and a lack of hormones in sex glands.


The AP analysis, supplemented by interviews with experts, shows too many sales and too many prescriptions for the number of people known to be suffering from those ailments. At least half of last year's sales likely went to patients not legally allowed to get the drug. And U.S. pharmacies processed nearly double the expected number of prescriptions.


Peddled as an elixir of life capable of turning middle-aged bodies into lean machines, HGH — a synthesized form of the growth hormone made naturally by the human pituitary gland — winds up in the eager hands of affluent, aging users who hope to slow or even reverse the aging process.


Experts say these folks don't need the drug, and may be harmed by it. The supposed fountain-of-youth medicine can cause enlargement of breast tissue, carpal tunnel syndrome and swelling of hands and feet. Ironically, it also can contribute to aging ailments like heart disease and Type 2 diabetes.


Others in the medical establishment also are taking a fat piece of the profits — doctors who fudge prescriptions, as well as pharmacists and distributors who are content to look the other way. HGH also is sold directly without prescriptions, as new-age snake oil, to patients at anti-aging clinics that operate more like automated drug mills.


Years of raids, sports scandals and media attention haven't stopped major drugmakers from selling a whopping $1.4 billion worth of HGH in the U.S. last year. That's more than industry-wide annual gross sales for penicillin or prescription allergy medicine. Anti-aging HGH regimens vary greatly, with a yearly cost typically ranging from $6,000 to $12,000 for three to six self-injections per week.


Across the U.S., the medication is often dispensed through prescriptions based on improper diagnoses, carefully crafted to exploit wiggle room in the law restricting use of HGH, the AP found.


HGH is often promoted on the Internet with the same kind of before-and-after photos found in miracle diet ads, along with wildly hyped claims of rapid muscle growth, loss of fat, greater vigor, and other exaggerated benefits to adults far beyond their physical prime. Sales also are driven by the personal endorsement of celebrities such as actress Suzanne Somers.


Pharmacies that once risked prosecution for using unauthorized, foreign HGH — improperly labeled as raw pharmaceutical ingredients and smuggled across the border — now simply dispense name brands, often for the same banned uses. And usually with impunity.


Eight companies have been granted permission to market HGH by the U.S. Food and Drug Administration, which reviews the benefits and risks of new drug products. By contrast, three companies are approved for the diabetes drug insulin.


The No. 1 maker, Roche subsidiary Genentech, had nearly $400 million in HGH sales in the U.S. last year, up an inflation-adjusted two-thirds from 2005. Pfizer and Eli Lilly were second and third with $300 million and $220 million in sales, respectively, according to IMS Health. Pfizer now gets more revenue from its HGH brand, Genotropin, than from Zoloft, its well-known depression medicine that lost patent protection.


On their face, the numbers make no sense to the recognized hormone doctors known as endocrinologists who provide legitimate HGH treatment to a small number of patients.


Endocrinologists estimate there are fewer than 45,000 U.S. patients who might legitimately take HGH. They would be expected to use roughly 180,000 prescriptions or refills each year, given that typical patients get three months' worth of HGH at a time, according to doctors and distributors.


Yet U.S. pharmacies last year supplied almost twice that much HGH — 340,000 orders — according to AP's analysis of IMS Health data.


While doctors say more than 90 percent of legitimate patients are children with stunted growth, 40 percent of 442 U.S. side-effect cases tied to HGH over the last year involved people age 18 or older, according to an AP analysis of FDA data. The average adult's age in those cases was 53, far beyond the prime age for sports. The oldest patients were in their 80s.


Some of these medical records even give explicit hints of use to combat aging, justifying treatment with reasons like fatigue, bone thinning and "off-label," which means treatment of an unapproved condition


Even Medicare, the government health program for older Americans, allowed 22,169 HGH prescriptions in 2010, a five-year increase of 78 percent, according to data released by the Centers for Medicare and Medicaid Services in response to an AP public records request.


"There's no question: a lot gets out," said hormone specialist Dr. Mark Molitch of Northwestern University, who helped write medical standards meant to limit HGH treatment to legitimate patients.


And those figures don't include HGH sold directly by doctors without prescriptions at scores of anti-aging medical practices and clinics around the country. Those numbers could only be tallied by drug makers, who have declined to say how many patients they supply and for what conditions.


First marketed in 1985 for children with stunted growth, HGH was soon misappropriated by adults intent on exploiting its modest muscle- and bone-building qualities. Congress limited HGH distribution to the handful of rare conditions in an extraordinary 1990 law, overriding the generally unrestricted right of doctors to prescribe medicines as they see fit.


Despite the law, illicit HGH spread around the sports world in the 1990s, making deep inroads into bodybuilding, college athletics, and professional leagues from baseball to cycling. The even larger banned market among older adults has flourished more recently.


FDA regulations ban the sale of HGH as an anti-aging drug. In fact, since 1990, prescribing it for things like weight loss and strength conditioning has been punishable by 5 to 10 years in prison.


Steve Kleppe, of Scottsdale, Ariz., a restaurant entrepreneur who has taken HGH for almost 15 years to keep feeling young, said he noticed a price jump of about 25 percent after the block on imports. He now buys HGH directly from a doctor at an annual cost of about $8,000 for himself and the same amount for his wife.


Many older patients go for HGH treatment to scores of anti-aging practices and clinics heavily concentrated in retirement states like Florida, Nevada, Arizona and California.


These sites are affiliated with hundreds of doctors who are rarely endocrinologists. Instead, many tout certification by the American Board of Anti-Aging and Regenerative Medicine, though the medical establishment does not recognize the group's bona fides.


The clinics offer personalized programs of "age management" to business executives, affluent retirees, and other patients of means, sometimes coupled with the amenities of a vacation resort. The operations insist there are few, if any, side effects from HGH. Mainstream medical authorities say otherwise.


A 2007 review of 31 medical studies showed swelling in half of HGH patients, with joint pain or diabetes in more than a fifth. A French study of about 7,000 people who took HGH as children found a 30 percent higher risk of death from causes like bone tumors and stroke, stirring a health advisory from U.S. authorities.


For proof that the drug works, marketers turn to images like the memorable one of pot-bellied septuagenarian Dr. Jeffry Life, supposedly transformed into a ripped hulk of himself by his own program available at the upscale Las Vegas-based Cenegenics Elite Health. (He declined to be interviewed.)


These promoters of HGH say there is a connection between the drop-off in growth hormone levels through adulthood and the physical decline that begins in late middle age. Replace the hormone, they say, and the aging process slows.


"It's an easy ruse. People equate hormones with youth," said Dr. Tom Perls, a leading industry critic who does aging research at Boston University. "It's a marketing dream come true."


___


Associated Press Writer David B. Caruso reported from New York and AP National Writer Jeff Donn reported from Plymouth, Mass. AP Writer Troy Thibodeaux provided data analysis assistance from New Orleans.


___


AP's interactive on the HGH investigation: http://hosted.ap.org/interactives/2012/hgh


___


The AP National Investigative Team can be reached at investigate(at)ap.org


EDITOR'S NOTE _ Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


Read More..

Wall Street sinks as "fiscal cliff" fears escalate

NEW YORK (Reuters) - U.S. stocks slid on Friday after a Republican plan to avoid the "fiscal cliff" failed to gain support on Thursday night, shrinking hopes that a deal would be reached before the new year.


Trading was volatile as investors lost confidence in the prospect of a deal between the White House and Republicans. Lower volume ahead of the Christmas and New Year's holidays exaggerated market swings. The CBOE Volatility Index <.vix> or VIX, the market's favored anxiety measure, rose 5 percent to 18.56, but was off the day's high.


Republican House Speaker John Boehner failed to garner enough votes even from his own party to pass his "Plan B" tax bill late on Thursday. This was the latest setback in negotiations to avoid $600 billion in tax hikes and spending cuts that some say could tip the U.S. economy into recession.


"The failure with Plan B was disappointing, if not terribly surprising, but now there's a real lack of clarity about what will happen, and markets hate that," said Mike Hennessy, managing director of investments for Morgan Creek in Chapel Hill, North Carolina.


The day's biggest loser on the New York Stock Exchange was Herbalife , which dropped for an eighth straight session. Investor Bill Ackman recently ramped up his campaign against the company. Herbalife skidded 19 percent to $27.25 and has lost more than 35 percent this week.


Plan B, which called for tax increases on those who earn $1 million or more a year, was not going to pass the Democratic-led Senate or win acceptance from the White House anyway. But it exposed the reality that it will be difficult to get Republican support for the more expansive tax increases that President Barack Obama has urged.


Still, the declines of about 1 percent in the three major U.S. stock indexes suggest that investors do not believe the economy will be unduly damaged by the absence of a deal, said Mark Lehmann, president of JMP Securities, in San Francisco.


"You could have easily woken up today and seen the market down 300 or 400 points, and everyone would have said, 'That's telling you this is really dire,'" Lehmann said.


"I think if you get into mid-January and (the talks) keep going like this, you get worried, but I don't think we're going to get there."


Banking shares, which outperform in times of economic expansion and have led the market on signs of progress with resolving the fiscal impasse, led declines. Citigroup Inc fell 2 percent to $39.35, while Bank of America slid 2.3 percent to $11.25. The KBW Banks index <.bkx> lost 1.4 percent.


The Dow Jones industrial average <.dji> dropped 142.29 points, or 1.07 percent, to 13,169.43. The Standard & Poor's 500 Index <.spx> dropped 15.69 points, or 1.09 percent, to 1,428.00. The Nasdaq Composite Index <.ixic> dropped 39.23 points, or 1.29 percent, to 3,011.15.


Even with the day's declines, the S&P 500 is up nearly 1 percent for the week and about 13 percent for the year.


The day's round of data indicated the economy was surprisingly resilient in November; consumer spending rose by the most in three years and a gauge of business investment jumped.


But separate data showed consumer sentiment slumped in December. The S&P Retail Index <.spxrt> fell 1.4 percent.


U.S.-listed shares of Research in Motion sank 21 percent to $11.09 after the Canadian company, known as the BlackBerry maker, reported its first-ever decline in its subscriber numbers on Thursday alongside a new fee structure for its high-margin services segment.


(Additional reporting by Ryan Vlastelica and Leah Schnurr; Editing by Bernadette Baum and Jan Paschal)



Read More..